Sami İlhan1, Rafet Günay2, Sevil Özkan3, Tolga Sinan Güvenç4, Nurgül Yurtsever5. 1. Clinic of Chest Diseases, Dr. Siyami Ersek Chest Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey. 2. Clinic of Cardiovascular Surgery, Dr. Siyami Ersek Chest Cardiovascular Surgery Training and Reseacrh Hospital, İstanbul, Turkey. 3. Clinic of Internal Medicine, Haydarpaşa Numune Training and Reseacrh Hospital, İstanbul, Turkey. 4. Clinic of Cardiology, Dr. Siyami Ersek Chest Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey. 5. Clinic of Anesthesiology, Dr. Siyami Ersek Chest Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Abstract
OBJECTIVES: We aimed to investigate the impact of arterial blood gas (ABG) on morbidity and mortality in chronic obstructive pulmonary disease (COPD) patients undergoing CABG surgery. MATERIAL AND METHODS: The records for 75 COPD patients who underwent elective CABG surgery our institution clinic between November 2008 to 2011 and had a forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ≤ 70% value in the pulmonary function tests (PFT) performed prior to the surgery were evaluated retrospectively. COPD patients were divided into two groups; Group 1; FEV1 ≥ 60% and Group 2; FEV1 ≤ 59%. Groups were compared for mortality and adverse events after identification of other preoperative and postoperative factors that could affect mortality and adverse events. An ABG was obtained immediately before and 3 to 6 hours after surgery to study the predictive value of ABG in seperate COPD groups. RESULTS: There were no significant differences in patients with high partial pressure carbondioxide (PaCO2) preoperative values compared to patients with normal values. Also there were no significant differences in patients with lower partial pressure of oxygen (PaO2) preoperative values compared to patients with normal values in terms of mortality. Postoperative myocardial infarction (MI) was significantly higher in patients with low PaO2 values (p< 0.05). CONCLUSION: In conclusion, in our study, there could not be found a relation between the degree of preoperative obstruction and mortality for COPD patients who underwent CABG surgery. ABG was not found useful for predicting mortality in COPD patients undergoing CABG surgery, but could be useful to predict postoperative MI in patients with COPD.
OBJECTIVES: We aimed to investigate the impact of arterial blood gas (ABG) on morbidity and mortality in chronic obstructive pulmonary disease (COPD) patients undergoing CABG surgery. MATERIAL AND METHODS: The records for 75 COPDpatients who underwent elective CABG surgery our institution clinic between November 2008 to 2011 and had a forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ≤ 70% value in the pulmonary function tests (PFT) performed prior to the surgery were evaluated retrospectively. COPDpatients were divided into two groups; Group 1; FEV1 ≥ 60% and Group 2; FEV1 ≤ 59%. Groups were compared for mortality and adverse events after identification of other preoperative and postoperative factors that could affect mortality and adverse events. An ABG was obtained immediately before and 3 to 6 hours after surgery to study the predictive value of ABG in seperate COPD groups. RESULTS: There were no significant differences in patients with high partial pressure carbondioxide (PaCO2) preoperative values compared to patients with normal values. Also there were no significant differences in patients with lower partial pressure of oxygen (PaO2) preoperative values compared to patients with normal values in terms of mortality. Postoperative myocardial infarction (MI) was significantly higher in patients with low PaO2 values (p< 0.05). CONCLUSION: In conclusion, in our study, there could not be found a relation between the degree of preoperative obstruction and mortality for COPDpatients who underwent CABG surgery. ABG was not found useful for predicting mortality in COPDpatients undergoing CABG surgery, but could be useful to predict postoperative MI in patients with COPD.
Authors: Rafael García Fuster; José A Montero Argudo; Oscar Gil Albarova; Fernando Hornero Sos; Sergio Cánovas López; María Bueno Codoñer; José A Buendía Miñano; Ignacio Rodríguez Albarran Journal: Eur J Cardiothorac Surg Date: 2005-12-20 Impact factor: 4.191
Authors: A Selcuk Adabag; Heba S Wassif; Kathryn Rice; Salima Mithani; Deborah Johnson; Jana Bonawitz-Conlin; Herbert B Ward; Edward O McFalls; Michael A Kuskowski; Rosemary F Kelly Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: L Fuso; L Cisternino; A Di Napoli; V Di Cosmo; L M Tramaglino; S Basso; S Spadaro; R Pistelli Journal: Respir Med Date: 2000-12 Impact factor: 3.415
Authors: Niv Ad; Linda Henry; Linda Halpin; Sharon Hunt; Scott Barnett; Pamela Crippen; Susan de Bullet; James Lamberti Journal: J Thorac Cardiovasc Surg Date: 2009-12-11 Impact factor: 5.209